四川双马(000935.SZ)：原料药生产基地湖北健翔已建成10条符合欧盟、FDA要求的多肽原料药生产线

Group 1 - The company Sichuan Shuangma (000935.SZ) has confirmed that its raw material drug production base, Hubei Jianxiang, has completed 10 production lines for peptide raw materials that meet EU and FDA standards [1] - The construction of the A16 workshop at Hubei Jianxiang is currently underway, and once completed, it will significantly enhance production capacity [1]